nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Ototoxicity—Isotretinoin—peripheral nervous system neoplasm	0.0538	0.0538	CcSEcCtD
Capreomycin—Ototoxicity—Tretinoin—peripheral nervous system neoplasm	0.0538	0.0538	CcSEcCtD
Capreomycin—Ototoxicity—Alitretinoin—peripheral nervous system neoplasm	0.0408	0.0408	CcSEcCtD
Capreomycin—Ototoxicity—Cisplatin—peripheral nervous system neoplasm	0.0347	0.0347	CcSEcCtD
Capreomycin—Renal tubular necrosis—Tretinoin—peripheral nervous system neoplasm	0.0302	0.0302	CcSEcCtD
Capreomycin—Renal tubular necrosis—Isotretinoin—peripheral nervous system neoplasm	0.0302	0.0302	CcSEcCtD
Capreomycin—Renal tubular necrosis—Alitretinoin—peripheral nervous system neoplasm	0.0229	0.0229	CcSEcCtD
Capreomycin—Nephrotoxicity—Cisplatin—peripheral nervous system neoplasm	0.0219	0.0219	CcSEcCtD
Capreomycin—Foetor hepaticus—Isotretinoin—peripheral nervous system neoplasm	0.019	0.019	CcSEcCtD
Capreomycin—Foetor hepaticus—Tretinoin—peripheral nervous system neoplasm	0.019	0.019	CcSEcCtD
Capreomycin—Foetor hepaticus—Melphalan—peripheral nervous system neoplasm	0.0188	0.0188	CcSEcCtD
Capreomycin—Liver disorder—Isotretinoin—peripheral nervous system neoplasm	0.0158	0.0158	CcSEcCtD
Capreomycin—Liver disorder—Tretinoin—peripheral nervous system neoplasm	0.0158	0.0158	CcSEcCtD
Capreomycin—Liver disorder—Melphalan—peripheral nervous system neoplasm	0.0156	0.0156	CcSEcCtD
Capreomycin—Foetor hepaticus—Alitretinoin—peripheral nervous system neoplasm	0.0144	0.0144	CcSEcCtD
Capreomycin—Induration—Etoposide—peripheral nervous system neoplasm	0.0143	0.0143	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.0123	0.0123	CcSEcCtD
Capreomycin—Nephropathy toxic—Cisplatin—peripheral nervous system neoplasm	0.0121	0.0121	CcSEcCtD
Capreomycin—Liver disorder—Alitretinoin—peripheral nervous system neoplasm	0.012	0.012	CcSEcCtD
Capreomycin—Leukocytosis—Tretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Capreomycin—Leukocytosis—Isotretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Capreomycin—Hearing impaired—Tretinoin—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Capreomycin—Hearing impaired—Isotretinoin—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Capreomycin—Nephropathy toxic—Etoposide—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Capreomycin—Hepatocellular injury—Tretinoin—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Capreomycin—Hepatocellular injury—Isotretinoin—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Capreomycin—Hepatocellular injury—Melphalan—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Capreomycin—Hypocalcaemia—Dactinomycin—peripheral nervous system neoplasm	0.00964	0.00964	CcSEcCtD
Capreomycin—Abscess—Cisplatin—peripheral nervous system neoplasm	0.00881	0.00881	CcSEcCtD
Capreomycin—Deafness—Tretinoin—peripheral nervous system neoplasm	0.00876	0.00876	CcSEcCtD
Capreomycin—Deafness—Isotretinoin—peripheral nervous system neoplasm	0.00876	0.00876	CcSEcCtD
Capreomycin—Leukocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00871	0.00871	CcSEcCtD
Capreomycin—Hearing impaired—Alitretinoin—peripheral nervous system neoplasm	0.0086	0.0086	CcSEcCtD
Capreomycin—Renal impairment—Tretinoin—peripheral nervous system neoplasm	0.00824	0.00824	CcSEcCtD
Capreomycin—Renal impairment—Isotretinoin—peripheral nervous system neoplasm	0.00824	0.00824	CcSEcCtD
Capreomycin—Hepatocellular injury—Alitretinoin—peripheral nervous system neoplasm	0.00818	0.00818	CcSEcCtD
Capreomycin—Hearing impaired—Cisplatin—peripheral nervous system neoplasm	0.00733	0.00733	CcSEcCtD
Capreomycin—Hepatocellular injury—Cisplatin—peripheral nervous system neoplasm	0.00697	0.00697	CcSEcCtD
Capreomycin—Deafness—Alitretinoin—peripheral nervous system neoplasm	0.00664	0.00664	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—peripheral nervous system neoplasm	0.00647	0.00647	CcSEcCtD
Capreomycin—Deafness—Vincristine—peripheral nervous system neoplasm	0.0064	0.0064	CcSEcCtD
Capreomycin—Renal impairment—Alitretinoin—peripheral nervous system neoplasm	0.00624	0.00624	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—peripheral nervous system neoplasm	0.00609	0.00609	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—peripheral nervous system neoplasm	0.00598	0.00598	CcSEcCtD
Capreomycin—Renal failure—Tretinoin—peripheral nervous system neoplasm	0.00594	0.00594	CcSEcCtD
Capreomycin—Renal failure—Isotretinoin—peripheral nervous system neoplasm	0.00594	0.00594	CcSEcCtD
Capreomycin—Deafness—Cisplatin—peripheral nervous system neoplasm	0.00566	0.00566	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—peripheral nervous system neoplasm	0.00564	0.00564	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00563	0.00563	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—peripheral nervous system neoplasm	0.00522	0.00522	CcSEcCtD
Capreomycin—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.00506	0.00506	CcSEcCtD
Capreomycin—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.00506	0.00506	CcSEcCtD
Capreomycin—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Capreomycin—Abscess—Epirubicin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Capreomycin—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.0045	0.0045	CcSEcCtD
Capreomycin—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00426	0.00426	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—peripheral nervous system neoplasm	0.00419	0.00419	CcSEcCtD
Capreomycin—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—peripheral nervous system neoplasm	0.00389	0.00389	CcSEcCtD
Capreomycin—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Capreomycin—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Capreomycin—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Capreomycin—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Capreomycin—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Capreomycin—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00372	0.00372	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Capreomycin—Renal failure—Etoposide—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Capreomycin—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Capreomycin—Pain—Topotecan—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Capreomycin—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Capreomycin—Pain—Tretinoin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Capreomycin—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Capreomycin—Pain—Melphalan—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Capreomycin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Capreomycin—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Capreomycin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Capreomycin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Capreomycin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Capreomycin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Capreomycin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Capreomycin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Capreomycin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Capreomycin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Capreomycin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Capreomycin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Capreomycin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Capreomycin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Capreomycin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Capreomycin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Capreomycin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Capreomycin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Capreomycin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Capreomycin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Capreomycin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Capreomycin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Capreomycin—Rash—Topotecan—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Capreomycin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Capreomycin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Capreomycin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Capreomycin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Capreomycin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Capreomycin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Capreomycin—Pain—Vincristine—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Capreomycin—Rash—Melphalan—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Capreomycin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Capreomycin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Capreomycin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Capreomycin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Capreomycin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Capreomycin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Capreomycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Capreomycin—Pain—Cisplatin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Capreomycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Capreomycin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Capreomycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Capreomycin—Pain—Etoposide—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Capreomycin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Capreomycin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Capreomycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Capreomycin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Capreomycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Capreomycin—Rash—Vincristine—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Capreomycin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Capreomycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Capreomycin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Capreomycin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Capreomycin—Rash—Etoposide—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Capreomycin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Capreomycin—Pain—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Capreomycin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000941	0.000941	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000939	0.000939	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000934	0.000934	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Capreomycin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Capreomycin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
